Cas:235093-98-8 3-Methylpyrrolidine hydrochloride (1:1) manufacturer & supplier

We serve Chemical Name:3-Methylpyrrolidine hydrochloride (1:1) CAS:235093-98-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Methylpyrrolidine hydrochloride (1:1)

Chemical Name:3-Methylpyrrolidine hydrochloride (1:1)
CAS.NO:235093-98-8
Synonyms:(3R)-3-Methylpyrrolidine hydrochloride (1:1);Pyrrolidine, 3-methyl-, hydrochloride (1:1);3-Methylpyrrolidine hydrochloride (1:1);Pyrrolidine, 3-methyl-, (3R)-, hydrochloride (1:1)
Molecular Formula:C5H12ClN
Molecular Weight:121.608
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:146.9ºC at 760 mmHg
Density:N/A
Index of Refraction:
PSA:12.03000
Exact Mass:121.065826
LogP:1.74660

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (3R)-3-Methylpyrrolidine hydrochloride (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Pyrrolidine, 3-methyl-, (3R)-, hydrochloride (1:1) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-Methylpyrrolidine hydrochloride (1:1) Use and application,3-Methylpyrrolidine hydrochloride (1:1) technical grade,usp/ep/jp grade.


Related News: In addition, AZ has been working to ink local commercialization deals to maintain its presence in China, Wang said. 5-Bromo-8-iodoquinoline manufacturers RELATED: With cost cuts and asset sales largely wrapped, Takeda gears up for growth: CEO 5-pyrazin-2-ylthiophene-2-carbaldehyde suppliers McNamara joined GSK from Novartis in 2015 when the two companies combined their OTC portfolios into a joint venture managed by GSK. He became head of GSK consumer health in 2016, taking the baton from Walmsley as she moved up the command chain to CEO of the entire group. Novartis in 2018 backed out of the collab, and after taking full control of the venture, GSK formed a new JV with Pfizer in 2019. 3-(chloroMethyl)-5-cyclopropyl-1,2,4-oxadiazole vendor & factory.